Cargando…
Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection
The severity of the SARS-CoV-2 pandemic and the recurring (re)emergence of viruses prompted the development of new therapeutic approaches that target viral and host factors crucial for viral infection. Among them, host peptidases cathepsins B and L have been described as essential enzymes during SAR...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287183/ https://www.ncbi.nlm.nih.gov/pubmed/37355023 http://dx.doi.org/10.1016/j.antiviral.2023.105655 |